Home Newsfeeds UBS Maintains Neutral on Beyond Meat, Raises Price Target to $30

UBS Maintains Neutral on Beyond Meat, Raises Price Target to $30

UBS analyst Cody Ross maintains Beyond Meat (NASDAQ:BYND) with a Neutral and raises the price target from $20 to $30.

byBenzinga Newsdesk

August 5, 2022

1 minute read

UBS analyst Cody Ross maintains Beyond Meat (NASDAQ:BYND) with a Neutral and raises the price target from $20 to $30.

Whirlpool Unveils +$60M Project To Create New Technology Center

By Lekha Gupta

August 18, 11:53 AM

Whirlpool Corp (NYSE: WHR) disclosed a new technology center in St.

WHR

News

The Joint Chiropractic Expands To Alaska, Signs Franchise Agreement For Three Clinics

By Benzinga Newsdesk

December 6, 9:53 AM

-First The Joint clinic opens in Wasilla, Alaska- SCOTTSDALE, Ariz., Dec. 6, 2022 /PRNewswire/ -- The Joint Corp. (NASDAQ:JYNT), the nation's largest provider of chiropractic care through The

JYNT

Semiconductor Sector (Mostly) Moves To The Green Despite TSMC’s Pessimistic Guidance: Find Out Why

By Natan Ponieman

April 20, 3:06 PM

Stock from Taiwan Semiconductor Mfg. Co. Ltd. (NYSE:TSM) rose 4.1% by mid-day Thursday, even as the company predicted…

AAPL

Taysha Gene Therapies Provides Clinical Updates For Investigational Programs TSHA-120 In Giant Axonal Neuropathy And TSHA-102 In Rett Syndrome At R&D Day

By Happy Mohamed

June 28, 8:17 AM

Company views that results of comprehensive data analysis of TSHA-120 and development of disease progression model (DPM) address U.S. Food and Drug Administration (FDA) feedback regarding the effort-dependent nature of

TSHA

UBS Maintains Neutral on Beyond Meat, Raises Price Target to $30

Related Posts

Whirlpool Unveils +$60M Project To Create New Technology Center

The Joint Chiropractic Expands To Alaska, Signs Franchise Agreement For Three Clinics

Semiconductor Sector (Mostly) Moves To The Green Despite TSMC’s Pessimistic Guidance: Find Out Why

Taysha Gene Therapies Provides Clinical Updates For Investigational Programs TSHA-120 In Giant Axonal Neuropathy And TSHA-102 In Rett Syndrome At R&D Day